• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
ALEXMED ePosters
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 7 (2025)
Volume Volume 6 (2024)
Volume Volume 5 (2023)
Volume Volume 4 (2022)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 3 (2021)
Volume Volume 2 (2020)
Volume Volume 1 (2019)
Khamis, M., Swelem, M., Khedr, M., Ibrahim, B. (2022). EVALUATION OF MATERNAL SERUM PENTRAXIN 3 AS A NOVEL DIAGNOSTIC BIOMARKER IN GESTATIONAL DIABETES MELLITUS. ALEXMED ePosters, 4(1), 46-47. doi: 10.21608/alexpo.2022.124724.1377
Mohamed Yousri Khamis; Manal Shafik Swelem; Marwa Ibrahim Abdelhalim Khedr; Bassant Saeed Basyouni Ibrahim. "EVALUATION OF MATERNAL SERUM PENTRAXIN 3 AS A NOVEL DIAGNOSTIC BIOMARKER IN GESTATIONAL DIABETES MELLITUS". ALEXMED ePosters, 4, 1, 2022, 46-47. doi: 10.21608/alexpo.2022.124724.1377
Khamis, M., Swelem, M., Khedr, M., Ibrahim, B. (2022). 'EVALUATION OF MATERNAL SERUM PENTRAXIN 3 AS A NOVEL DIAGNOSTIC BIOMARKER IN GESTATIONAL DIABETES MELLITUS', ALEXMED ePosters, 4(1), pp. 46-47. doi: 10.21608/alexpo.2022.124724.1377
Khamis, M., Swelem, M., Khedr, M., Ibrahim, B. EVALUATION OF MATERNAL SERUM PENTRAXIN 3 AS A NOVEL DIAGNOSTIC BIOMARKER IN GESTATIONAL DIABETES MELLITUS. ALEXMED ePosters, 2022; 4(1): 46-47. doi: 10.21608/alexpo.2022.124724.1377

EVALUATION OF MATERNAL SERUM PENTRAXIN 3 AS A NOVEL DIAGNOSTIC BIOMARKER IN GESTATIONAL DIABETES MELLITUS

Article 1, Volume 4, Issue 1, March 2022, Page 46-47  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2022.124724.1377
View on SCiNiTO View on SCiNiTO
Authors
Mohamed Yousri Khamis1; Manal Shafik Swelem2; Marwa Ibrahim Abdelhalim Khedr3; Bassant Saeed Basyouni Ibrahim email 1
1Department of Obstetrics and Gynecology, Faculty of Medicine, Alexandria University
2Department of obstetrics and gynaecology, Faculty of medicine
3Department of Medical Biochemistry, Faculty of Medicine, Alexandria University
Abstract
Gestational diabetes mellitus (GDM) is the type of glucose intolerance that develops in the second and third trimester of pregnancy, resulting in hyperglycemia of variable severity. It is the most common metabolic disorder of pregnancy.
The oral glucose tolerance test (OGTT) is considered the cornerstone of the diagnosis of gestational diabetes mellitus (GDM). Earlier detection of GDM may lead to improved management, possibly preventing pregnancy complications. Thus, the identification of sensitive and specific biomarkers, which may offer potential for risk prediction and intervention strategies, became a major focus in GDM research.
Pentraxins are a superfamily of evolutionarily conserved molecules with multi-functional roles in innate immunity and inflammation. They are essential constituents of the humoral arm of innate immunity and represent a superfamily of highly conserved acute phase proteins. Pentraxin 3 (PTX3) is the prototype of the long pentraxin subfamily.
In recent years, chronic subclinical inflammation is considered to have a potential role in the pathogenesis of hyperglycemia and pentraxin 3 (PTX3) as an inflammatory mediator, is correlated with the process of insulin resistance and its level is also increased in diabetes mellitus and diabetic nephropathy.
The OGTT is beloved by very few, and validation of alternative, less cumbersome strategies for diagnosis and classification of GDM are needed.
Keywords
Gestational diabetes mellitus (GDM); oral glucose tolerance test (OGTT); Pentraxin 3 (PTX3)
Supplementary Files
download 1377 12.pdf
Statistics
Article View: 138
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.